Prolonged viral suppression with anti-HIV-1 antibody therapy

HIV-1 infection remains a public health problem with no cure. Anti-retroviral therapy (ART) is effective but requires lifelong drug administration owing to a stable reservoir of latent proviruses integrated into the genome of CD4(+) T cells(1). Immunotherapy with anti-HIV-1 antibodies has the potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaebler, Christian, Nogueira, Lilian, Stoffel, Elina, Oliveira, Thiago Y., Breton, Gaëlle, Millard, Katrina G., Turroja, Martina, Butler, Allison, Ramos, Victor, Seaman, Michael S., Reeves, Jacqueline D., Petroupoulos, Christos J., Shimeliovich, Irina, Gazumyan, Anna, Jiang, Caroline S., Jilg, Nikolaus, Scheid, Johannes F., Gandhi, Rajesh, Walker, Bruce D., Sneller, Michael C., Fauci, Anthony, Chun, Tae-Wook, Caskey, Marina, Nussenzweig, Michel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177424/
https://www.ncbi.nlm.nih.gov/pubmed/35418681
http://dx.doi.org/10.1038/s41586-022-04597-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177424/
https://www.ncbi.nlm.nih.gov/pubmed/35418681
http://dx.doi.org/10.1038/s41586-022-04597-1

Ejemplares similares